Economic Evaluation of Anastrozole Versus Tamoxifen for Early Stage Breast Cancer in Singapore Vivianne Shih, PharmD, BCOP, BCPS, Alexandre Chan, PharmD, MPH, BCPS, BCOP, Feng Xie, PhD, Yu Ko, PhD Value in Health Regional Issues Volume 1, Issue 1, Pages 46-53 (May 2012) DOI: 10.1016/j.vhri.2012.03.013 Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions
Fig. 1 Simplified structure of the Markov model. Value in Health Regional Issues 2012 1, 46-53DOI: (10.1016/j.vhri.2012.03.013) Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions
Fig. 2 Tornado diagram for incremental cost/QALY comparing anastrozole with tamoxifen. Value in Health Regional Issues 2012 1, 46-53DOI: (10.1016/j.vhri.2012.03.013) Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions